About Cogentix Medical
Cogentix Medical, Inc. is a global medical company that provides proprietary, innovative technologies to specialty markets including urology, gynecology, bariatric medicine, critical care, gastroenterology, otolaryngology, and pulmonology. Our products are designed to increase treatment efficiency, lower patient risk and provide customer value.
Cogentix Medical was formed in 2015 following the merger of two established medical device companies: Uroplasty, a urology company focused on bulking agents and office-based neuromodulation, and Vision-Sciences, the company that introduced an innovative sterile, sheathed-endoscope technology, which revolutionizes efficiency and safety in endoscopy.
Urgent PC Neuromodulation System is an effective, office-based method of treating overactive bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is also indicated for the treatment of fecal incontinence outside the US market. Urgent PC is delivered in simple 30-minute treatments that are low-risk and associated with minimal side effects. Clinical trials and published studies have shown PTNS to be clinically effective in up to 80% of patients.
PrimeSight Endoscopy Systems from Cogentix Medical combine state-of-the-art endoscopic instrumentation with the EndoSheath® protective barrier, a sterile single-use product with an integrated working channel, to offer practitioners and healthcare facilities a solution to meet the growing need for safe, efficient, and cost effective endoscopy. Cogentix Medical offers video and fiberoptic endoscopy systems that are used in Cystoscopy, Laryngoscopy, Bronchoscopy, and Transnasal Esophagoscopy. In addition, Cogentix Medical offers a variety of endoscopy accessories.
Bulking Agents are available from Cogentix Medical to meet a variety of bulking needs. Macroplastique® is the most established product for soft tissue augmentation for the endoscopic treatment of stress urinary incontinence (SUI). Other Cogentix Medical bulking agents are used in vocal cord rehabilitation and fecal incontinence. Product availability and clearances vary by country.
Cogentix Medical currently has over forty issued patents in the United States and other key countries, and a number of additional patent applications in process. These patents, as well as additional intellectual property, provide a robust technology base for future growth.